Get startedLog in
    Picture of Egetis Therapeutics AB (publ) logo

    EGTX — Egetis Therapeutics AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    All News

    Brief: Egetis Submits Responses To European Medicines Agency's Day 120 List Of Questions

    Picture of Egetis Therapeutics AB (publ) logoEgetis Therapeutics AB (publ)
    14/08/2024 07:05
    Aug 14 (Reuters) - Egetis Therapeutics AB (publ)
 EGTX.ST :
    * SAYS SUBMITTED RESPONSES TO DAY 120 LIST OF QUESTIONS
RECEIVED
FROM EUROPEAN MEDICINES AGENCY FOR MARKETING AUTHORISATION
APPLICATION (MAA) FOR TIRATRICOL
    * NEXT EXPECTED STEP IN REVIEW PROCESS, DAY 180 LIST OF
OUTSTANDING ISSUES, IS EXPECTED IN OCTOBER 2024

Source text for Eikon:  ID:nMFN40HGhG 
Further company coverage:  EGTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Egetis Therapeutics AB (publ)

    See all news